PetMeds Appoints Jeff Willard as CEO as Online Pet-Health Retailer Begins New Leadership Phase

PetMed Express, Inc. (NASDAQ: PETS), operating as PetMeds and parent company of PetCareRx, has appointed Jeff Willard as Chief Executive Officer and President, effective 28 September 2026. Willard also joins the company’s Board of Directors.

The leadership transition marks a new phase for the U.S. online pet-health retailer, with Willard bringing more than 25 years of experience across consumer and e-commerce businesses. He succeeds Leslie C.G. Campbell, who had served as interim CEO and President since August 2025.

Board Leadership Also Changes

The CEO transition is accompanied by a broader change in PetMeds’ board leadership. Campbell is retiring as Board Chair and stepping down from the Board effective 28 September. Justin Mennen, currently PetMeds’ Lead Independent Director, becomes Chair.

Peter Batushansky will become Chair of the Corporate Governance and Nominating Committee, replacing Mennen in that role. Campbell will remain with the company for 60 days as a Strategic Advisor, providing continuity during the leadership transition.

PetMeds also recently appointed Tamar Elkeles as an independent director, while the company appointed Andrew Parry as Chief Technology Officer earlier in September. The sequence of appointments indicates that the leadership transition extends beyond the CEO position into governance and technology capabilities.

Why It Matters for Animal Health

PetMeds operates at an increasingly important intersection of veterinary medicine, e-commerce and direct-to-consumer pet healthcare.

The company describes its business as delivering pet medications, food, health services and other products directly to consumers through PetMeds.com and its telephone channel. This places the company within a rapidly evolving pet-health ecosystem involving:

• Online veterinary pharmacies

• Prescription management

• Preventive healthcare

• Chronic-condition medication

• Pet nutrition

• Replenishment/subscription models

• Digital customer acquisition

• Veterinary-client relationships

• DTC pet-health brands

Willard’s background is particularly relevant because the company has explicitly positioned his mandate around execution, sustainable profitability and growth.

Strategic / Analyst View

The leadership change should be watched as part of the wider evolution of digital pet healthcare in the United States.

Online pet-health platforms have an inherent advantage in recurring-care categories. Chronic medications, parasite-control products, supplements, therapeutic diets and other repeat-purchase products can potentially be managed through digital ordering and replenishment.

However, the model also depends on maintaining regulatory compliance, prescription workflows, veterinary relationships, customer trust, fulfilment efficiency and appropriate product economics.

PetMeds’ simultaneous strengthening of technology leadership and board governance, together with the CEO transition, therefore provides a useful indicator of the strategic priorities facing scaled digital pet-health retailers.

Implications for Animal-Health Companies

For pharmaceutical and consumer-health companies, online pet pharmacies represent an increasingly important distribution and customer-engagement channel. The evolution of PetMeds could influence how manufacturers approach:

Veterinary recommendation → prescription → digital fulfilment → recurring purchase → adherence → preventive-care engagement

This model is particularly relevant to chronic pet-health conditions and repeat-use products.

Outlook

Jeff Willard’s appointment puts a consumer and e-commerce executive at the helm of a specialised pet-health retailer at a time when veterinary care, pet medications and digital commerce are increasingly converging.

The next phase for PetMeds will be closely watched for its impact on customer acquisition, digital conversion, recurring purchases, operational efficiency and integration between online pet retail and veterinary healthcare.

For the wider animal-health industry, the development reinforces the growing importance of digital distribution as part of the companion-animal healthcare value chain.